Subject(s)
Aortic Diseases/diagnostic imaging , Duodenal Diseases/diagnostic imaging , Intestinal Fistula/diagnostic imaging , Vascular Fistula/diagnostic imaging , Aged , Aorta, Thoracic , Aortic Diseases/pathology , Aortic Diseases/surgery , Diagnosis, Differential , Duodenal Diseases/pathology , Duodenal Diseases/surgery , Endoscopy, Gastrointestinal , Humans , Intestinal Fistula/pathology , Intestinal Fistula/surgery , Male , Tomography, X-Ray Computed , Vascular Fistula/pathology , Vascular Fistula/surgery , Vascular Surgical ProceduresSubject(s)
Rectal Diseases/etiology , Self-Injurious Behavior/complications , Ulcer/etiology , Defecation , Female , Humans , Middle Aged , Rectum/injuriesSubject(s)
Crohn Disease/pathology , Duodenum/pathology , Endoscopy, Gastrointestinal , Adolescent , Female , HumansABSTRACT
Among 39 patients with pyogenic liver abscess who were admitted to our institute, six (15%) were infected by Streptococcus milleri (S. milleri). We investigated clinical features of these six patients. There were five males and one female, aged 43-81 years old (mean: 61). Five of the six patients had underlying illness. All patients had fever, and three of them complained of abdominal pain. Three patients had mixed infections; particularly intraoral anaerobes, Fusobacterium, were found in two of the three patients. There were no differences in clinical features between patients with S. milleri liver abscess and those with other bacterial liver abscess. In conclusion, on selecting antibiotics for the treatment of liver abscess, it is necessary to consider the S. milleri and intraoral anaerobes.
Subject(s)
Liver Abscess/microbiology , Streptococcal Infections/microbiology , Streptococcus/isolation & purification , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Streptococcus/pathogenicityABSTRACT
Recently, there have been many highly sensitive methods for CRP assay. However, there are also many factors that interfere with CRP assay. We are taking measures to avoid interference due to factors such as, myeloma protein, rheumatoid factor, lipaemia(a substance similar to detergent in the capillary tube, etc). Currently CRP assay methods which are not influenced by these factors are available. However, other unknown factors that interfere with CRP assay have become apparent. We think that these are peculiar to the immunoassay. We are taking measures to identify these interference factors and resolve the problem. In the following, we will explain some experiments that will protect our re-agent from these interference factors.